This announcement is a separate document:
东诚药业：关于控股子公司获得药物临床试验批准通知书的公告
Yantai Dongcheng Biochemicals: Announcement Regarding the Holding Subsidiary Receiving Drug Clinical Trial Approval Notification
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated